Fungal virus, attenuated strain, plant disease control agent and application thereof

Through the application of fungal virus CaPV1 and attenuated strain YC-31, the problems of chemical pesticide resistance and environmental pollution are solved, and low-toxic biological control of plant pathogenic fungi are achieved, which reduces pathogenicity and enhances the sensitivity of the agent. Provide a safe and efficient prevention and control method.

CN115927208BActive Publication Date: 2024-11-19HUNAN AGRI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211008989.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-08-22
Publication Date
2024-11-19
Estimated Expiration
2042-08-22

AI Technical Summary

Technical Problem

The existing chemical pesticides are used to prevent and control fungal diseases of the genus genus ceramide, which leads to a decrease in drug efficacy, environmental pollution and health hazards, and lacks efficient and safe biological control methods.

Method used

A fungal virus CaPV1 and its attenuated strain YC-31 were developed to reduce the pathogenicity of plant pathogenic fungi through virion transfection, affecting mycelial growth, spore morphology and agent sensitivity, and are used to prepare plant disease prevention and treatment. agent.

Benefits of technology

It effectively reduces the pathogenicity of plant pathogenic fungi, enhances the sensitivity to certain agents, provides a low-toxic biological control method, reduces the use of chemical pesticides, and reduces environmental and health risks.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115927208B_ABST
    Figure CN115927208B_ABST
Patent Text Reader

Abstract

The present invention provides a fungal virus, an attenuated strain, a plant disease control agent and application, and relates to the technical field of biological control, including the function of inhibiting plant disease fungi, and having two double-stranded RNAs of 1.6 to 1.8 kb, the nucleotide sequences of the two double-stranded RNAs are shown in SEQ ID NOs: 1 and 2. The fungal virus provided by the present invention can affect the growth, spore morphology and endocytosis of host hyphae and the sensitivity of the host to the drugs carbendazim, prochloraz and azoxystrobin, thereby achieving the purpose of being able to effectively control plant diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biological control, and in particular to a fungal virus, an attenuated strain, a plant disease control agent and applications thereof. Background Art

[0002] Among plant diseases, fungi are one of the most important pathogens, accounting for about 80% of plant diseases, causing huge economic losses to agricultural production every year. Currently, the prevention and control of fungal diseases mainly relies on chemical agents, and the continuous application of chemical pesticides can easily lead to the emergence of drug-resistant strains, resulting in a decrease in drug efficacy, which not only increases costs but also pollutes the environment and endangers human health. Therefore, finding efficient and safe prevention and control methods is of great significance for the prevention and control of fungal diseases.

[0003] Fungal viruses or mycoviruses are a class of viruses that can infect fungi and are widely present in various fungi, including plant pathogenic fungi. Most fungal viruses are asymptomatic mixed infections in the host. Some hypotoxic fungal viruses (hypoviruses) can usually cause host growth defects, reduced pigment synthesis, reduced spore production, and decreased pathogenicity, etc. They can be used as potential biocontrol factors in the biological control of plant fungal diseases and can be used for the prevention and control of plant fungal diseases. Therefore, exploring low-toxic fungal viruses with biocontrol potential is of great significance for the use of fungal viruses to control plant fungal diseases.

[0004] Colletotrichum spp. is a very important plant pathogenic fungus that can cause diseases of many woody and herbaceous plants. This genus of pathogens can infect up to 30 genera of plants, causing significant losses to fruits with large yields and high economic value, such as mango, strawberry, citrus, avocado and banana; it is also a serious threat to grains such as corn and sorghum, as well as sugarcane. Due to the serious economic losses and strong destructiveness caused by this genus of fungi, and based on its scientific and economic value, this genus of pathogens was once selected as the eighth most important plant pathogenic fungi in the world. At present, the prevention and control of this disease mainly adopts chemical methods, but the long-term use of chemical agents will bring about a series of related problems such as ecological balance destruction, environmental pollution and pathogen resistance, which are becoming increasingly serious. Summary of the invention

[0005] In order to solve the technical problem of the diseases caused by the genus Colletotrichum on woody and herbaceous plants, the present invention provides the following solutions:

[0006] The fungal virus is isolated from a strain with a preservation number of CCTCC NO: M20221146, has the function of inhibiting plant disease fungi, and has two double-stranded RNAs of 1.6 to 1.8 kb. The nucleotide sequences of the two double-stranded RNAs are shown in SEQ ID NOs: 1 and 2.

[0007] The attenuated strain contains the fungal virus, and its classification name is Colletotrichum alienum YC-31, and its preservation number is CCTCC NO: M20221146.

[0008] A plant disease control agent, which contains at least the fungal virus and / or the attenuated strain.

[0009] According to the application of fungal viruses or attenuated strains in inhibiting the pathogenicity of plant pathogenic fungi, the plant pathogenic fungi refer to: pathogenic fungi of the genus Colletotrichum.

[0010] According to the use of the fungal virus in extracellular infection of plant pathogenic fungi, the plant pathogenic fungi refer to pathogenic fungi of the genus Colletotrichum.

[0011] According to the use of the fungal virus or the attenuated strain in the preparation of a plant disease control agent caused by plant pathogenic fungi, the plant pathogenic fungi refer to: pathogenic fungi of the genus Colletotrichum.

[0012] The invention relates to a method for attenuating plant pathogenic fungi, which utilizes the fungal virus to infect the plant pathogenic fungi in vitro.

[0013] The method for controlling plant pathogenic fungi comprises adding the plant disease control agent to plants.

[0014] The present invention provides a fungal virus and an attenuated strain having the fungal virus. The fungal virus has low toxicity, and the attenuated strain can inhibit the pathogenicity of plant pathogenic fungi. Specifically, the attenuated strain contains the fungal virus, and the fungal virus can affect the mycelial growth, spore morphology, endocytosis of the host, and the sensitivity of the host to the drugs carbendazim, prochloraz, and azoxystrobin.

[0015] In addition, the fungal virus can be transmitted across species to pathogenic fungi such as fruit anthracnose (C. fructicola), ash anthracnose (C. spaethianum) and gloeosporioides (C. gloeosporioides) through viral particle transfection, reducing their pathogenicity.

[0016] The attenuated strain was grown and separated from oil-tea camellia fruits in the field in Yongding District, Zhangjiajie City, Hunan Province. After isolation and identification, the strain was named Colletotrichum alienum according to classification. It was deposited in the China Center for Type Culture Collection on July 21, 2022, with the address: Wuhan University, Wuhan, China, and the collection number is CCTCCM20221146.

[0017] Further research found that the attenuated strain YC-31 contained a naturally occurring fungal virus with two double-stranded RNAs of 1.6 to 1.8 kb. The full genome sequence of the fungal virus was obtained by high-throughput sequencing technology and ligase-mediated end cloning method, and it was named Colletotrichum alienum partitivirus 1, abbreviated as CaPV1. The fungal virus CaPV1 gene had two genome sequences such as SEQ ID NO: 1 to 2. The fungal virus CaPV1 contained conservative motifs of RdRp (RNA-dependent RNA polymerase) and CP (capsid protein) in the double-stranded RNA sequence, and the nucleotide sequence encoding RdRp had homology with the known Metarhizium brunneum partitivirus 2, and the CP nucleotide sequence had homology with the known Colletotrichum partitivirus 1. Therefore, based on genome structure analysis, sequence homology comparison and phylogenetic analysis, it is speculated that the fungal virus CaPV1 is a new type of fungal virus.

[0018] After the attenuated strain YC-31 was detoxified by protoplast regeneration technology, the detoxified strains YC-31-P23 and YC-31-P29 of the attenuated strain YC-31 were obtained. After research, it was found that the pathogenicity of the pathogen after detoxification was restored. The fungal virus CaPV1 provided by the present invention can be transmitted to the detoxified strain YC-31-P23 through viral particle transfection, and then the attenuated strain YC-31-P23-T1 is obtained, and the pathogenicity of the attenuated strain is significantly weakened. Therefore, it can be concluded that the fungal virus CaPV1 can reduce the pathogenicity of the host.

[0019] Through observation, it was found that the hyphae of the attenuated strain YC-31 provided by the present invention were sparse and had fewer branches, while the hyphae of the detoxified strain YC-31-P23 were denser and had more branches, so it was speculated that the attenuated fungus CaPV1 affected the growth of host hyphae. In addition, in terms of spore morphology, the conidia of the attenuated strain YC-31 were cylindrical, elliptical or elongated, with blunt ends or slightly pointed ends, and abnormal elongated conidia appeared, with a size of 10.1-26.7×3.9-8.9μm (av=15.92+0.65×5.81+0.15, n=50). The conidia of the virus-free strain YC-31-P23 are cylindrical or elliptical, with blunt ends or one slightly pointed end, and the spore size is 7.5-15.2×3.5-6.4μm (av=12.04+0.28×4.83+0.08, n=50). Therefore, it can be concluded that the fungal virus CaPV1 affects the morphology of the host conidia.

[0020] The hyphae of the toxic strain YC-31 and the detoxified strain YC-31-P23 were stained with FM4-64 dye, and the endocytosis of the hyphae was observed with a fluorescence microscope. The results showed that in the detoxified strain YC-31-P23, the absorption of the dye was very rapid, while in the attenuated strain YC-31 provided by the present invention, the entry of the dye into the hyphae was significantly blocked, and only a small amount of the dye was absorbed by the hyphae until 30 minutes. Therefore, it is proved that the fungal virus CaPV1 can affect the endocytosis of the host.

[0021] The attenuated strain YC-31 and the detoxified strain YC-31-P23 provided by the present invention were subjected to drug sensitivity tests using carbendazim, prochloraz, and azoxystrobin. The attenuated strain YC-31 provided by the present invention was more sensitive to carbendazim and prochloraz than the detoxified strain YC-31-P23, but less sensitive to azoxystrobin than the detoxified strain YC-31-P23. It is thus inferred that the fungal virus CaPV1 affects the sensitivity of the host to the drug, thereby enhancing the sensitivity to carbendazim and prochloraz, while reducing the sensitivity to azoxystrobin.

[0022] The fungal virus CaPV1 provided by the present invention is transmitted across species to C. fructicola Cf10-6 strain and LY5-1 strain, C. spaethianum Cs4-1 strain and C. gloeosporioides Cg2-1 strain through virus particle transfection, and the strains obtained by the virus also show a significant reduction in pathogenicity. Therefore, the fungal virus CaPV1 can infect the host bacteria through particle transfection, so that the host bacteria contain the fungal virus, thereby reducing the pathogenicity of plant pathogenic fungi and achieving the purpose of biological control of plant fungal diseases.

[0023] The fungal virus provided by the invention can affect the growth, spore morphology and endocytosis of host hyphae and the sensitivity of the host to the drugs carbendazim, prochloraz and azoxystrobin, thereby achieving the purpose of being able to effectively prevent and control plant diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the technical solution of the present invention, the accompanying drawings required for use in the present invention will be briefly introduced below. It should be understood that the following accompanying drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these accompanying drawings without paying creative work.

[0025] Figure 1 The colony diagram of the attenuated strain YC-31 provided by the present invention;

[0026] Figure 2 The electrophoresis diagram of double-stranded RNA in the attenuated strain YC-31 provided by the present invention, wherein: M is a 5000bp Marker;

[0027] Figure 3 A schematic diagram of the structure of the fungal virus CaPV1 genome provided by the present invention;

[0028] Figure 4 A phylogenetic tree constructed for the fungal virus CaPV1 RdRp sequence provided by the present invention;

[0029] Figure 5 The virus particles of the fungal virus CaPV1 extracted from the attenuated strain YC-31 provided by the present invention, wherein: A: electrophoresis diagram of virus particle protein of the fungal virus CaPV1, B: electron microscope photo of virus particles of the fungal virus CaPV1, C: electrophoresis diagram of dsRNA after nucleic acid extraction from virus particles of the fungal virus CaPV1;

[0030] Figure 6 Colony diagrams of the attenuated strain YC-31, the detoxified strains YC-31-P23 and YC-31-P29, and the detoxified and re-toxified strain YC-31-P23-T1 provided by the present invention on PDA culture medium;

[0031] Figure 7 The results of inoculating pears, camellia leaves and apples with the strain YC-31 of the present invention, the virus-free strains YC-31-P23 and YC-31-P29, and the virus-free and re-recovered strain YC-31-P23-T1, respectively;

[0032] Figure 8 The morphology of hyphae tips and spores of the attenuated strain YC-31 and the detoxified strain YC-31-P23 of the present invention is shown;

[0033] Fig. 9 The mycelia of the attenuated strain YC-31 and the detoxified strain YC-31-P23 of the present invention were stained with plasma membrane FM4-64 dye and observed under a fluorescence confocal microscope;

[0034] Fig.10 The sensitivity of the attenuated strain YC-31 and the detoxified strain YC-31-P23 of the present invention to carbendazim, prochloraz, and azoxystrobin;

[0035] Fig.11 This is a study on the control of plant pathogenic fungi by the fungal virus CaPV1 of the present invention, wherein: Cf10-6-V, LY5-1-V, Cs4-1-V, and Cg2-1-V represent strains infected with the virus. DETAILED DESCRIPTION

[0036] The technical solution of the present invention will be described below in conjunction with the accompanying drawings of the present invention.

[0037] <About the fungal virus of the present invention>

[0038] The fungal virus provided by the present invention is a fungal virus with the ability to inhibit the virulence of plant pathogenic fungi extracted from the attenuated strain YC-31, named Colletotrichum alienum partitivirus 1 (abbreviated as CaPV1), which has two double-stranded RNAs of 1.6 to 1.8 kb. Each virus particle of the fungal virus has two double-stranded RNAs of 1.6 to 1.8 kb, and the two double-stranded RNAs are wrapped in one virus particle, and exist and propagate at the same time. The colony of the attenuated strain YC-31 is as follows: Figure 1 shown.

[0039] The fungal virus contains a conserved motif of RdRp (RNA-dependent RNA polymerase) in the double-stranded RNA sequence, and the nucleotide sequence of the RNA encoding this region is highly homologous to the Metarhizium brunneum partitivirus 2 (MbPV2) virus, and has homology with the region encoding RdRp in the genome of viruses under the family Bipartiviridae. The fungal virus contains a conserved motif of CP (capsid protein) in the double-stranded RNA sequence, and the nucleotide sequence of the RNA encoding this region is highly homologous to the Colletotrichum partitivirus 1 (CPV1) virus, and has homology with the region encoding CP in the genome of viruses under the family Bipartiviridae.

[0040] The present invention has sequenced the fungal virus CaPV1 and obtained the full-length nucleotide sequence. Therefore, the present invention includes all the fungal virus genes, nucleic acids having the nucleotide sequence or a part thereof, proteins encoded by these nucleotide sequences, etc.

[0041] The nucleotide sequences of the two double-stranded RNAs of the virus are represented by SEQ ID NOs: 1 to 2, respectively. The present invention also includes all nucleic acids having all or part of the above nucleotide sequences. Nucleic acids may be double-stranded or single-stranded, and DNA, cDNA, RNA, etc. are also all included. For example, all or any of the sequences of SEQ ID NOs: 1 to 2, the sequence of a specific part having a prescribed function in the sequence, cDNA having the same nucleotide sequence as these sequences, and recombinant vectors (plasmids, viruses, etc.) having the same nucleotide sequence as these sequences inserted therein, etc., are all included in the present invention.

[0042] The results of sequence analysis showed that the conserved motif of RdRp (RNA-dependent RNA polymerase) exists in the sequence portion of SEQ ID NO: 1, and the conserved motif of CP (capsid protein) exists in the sequence portion of SEQ ID NO: 2. Therefore, according to the purpose and application, for example, nucleic acids, recombinant vectors, etc. having at least these sequence portions as specific portions having a prescribed function can also be prepared and used.

[0043] It should be noted that the nucleic acid (or gene) of the present invention also includes nucleic acids having homology with the above-mentioned nucleotide sequence, for example, nucleic acids that hybridize with nucleic acids composed of nucleotide sequences complementary to the nucleotide sequence under strict conditions and have fungal pathogenicity inhibitory effects.

[0044] As the host, known hosts such as Escherichia coli, yeast, and cultured cells can be considered. Considering that fungal viruses can infect fungi, yeast has high proliferation and is relatively easy to use, yeast may be the most suitable host. As for recombinant vectors, known vectors can also be used. Multiple vectors inserted with any sequence of SEQ ID NO: 1 to 2 may reconstitute fungal viruses by co-expressing genes of the two types. In this case, it is also possible to consider using known hosts and known recombinant vectors, but yeast may be the most suitable from the perspective of being able to introduce multiple vectors at the same time.

[0045] <About the preparation of plant pathogenic fungal viruses>

[0046] The fungal virus CaPV1 of the present invention is present in a predetermined strain of Colletotrichum anthracis YC-31, and therefore the fungal virus can be obtained by isolating and recovering the virus from the Colletotrichum anthracis YC-31 strain infected with the fungal virus CaPV1.

[0047] As a method for separating and recovering the virus, a known method can be used. For example, the bacteria can be frozen and broken with liquid nitrogen, suspended in a predetermined buffer, and then separated by ultracentrifugation to recover the virus.

[0048] However, the fungal virus CaPV1 of the present invention is not limited to the virus obtained by this production method. For example, viruses separated and recovered from anthrax bacteria containing the fungal virus CaPV1 are also broadly included in the present invention.

[0049] <About Methods for Attenuating Plant Pathogenic Fungi>

[0050] The fungal virus CaPV1 of the present invention can be used to infect specific plant pathogenic fungi, etc., thereby attenuating the fungi.

[0051] <About Plant Disease Control Agents>

[0052] The plant disease control agent of the present invention comprises all of at least one of the fungal virus CaPV1 provided by the present invention or the attenuated strain YC-31 provided by the present invention, and may also contain both the fungal virus CaPV1 and the attenuated strain YC-31, or may contain other ingredients.

[0053] As other ingredients, it may contain, for example, a prescribed carrier, a binder, a tackifier, a fixative, a preservative and a mildew preventer, a solvent, a stabilizer, an antioxidant, an ultraviolet absorber, a crystal precipitation inhibitor, a defoaming agent, a physical property improver, a colorant, etc. In addition, it may also contain other pesticide ingredients, such as acaricides, nematicides, fungicides, antiviral agents, attractants, herbicides, plant growth regulators, synergists, etc.

[0054] As a carrier, for example, a solid carrier and / or a liquid carrier can be used. As a solid carrier, for example, animal and plant powders such as starch, activated carbon, soybean flour, wheat flour, wood flour, fish meal, milk powder, and mineral powders such as talc, kaolin, bentonite, zeolite, diatomaceous earth, white carbon black, clay, aluminum oxide, calcium carbonate, potassium chloride, and ammonium sulfate can be listed. As a liquid carrier, for example, alcohols such as water, isopropanol, and ethylene glycol, ketones such as cyclohexanone and methyl ethyl ketone, ethers such as propylene glycol monomethyl ether and diethylene glycol mono-n-butyl ether, aliphatic hydrocarbons such as kerosene and light oil, aromatic hydrocarbons such as xylene, trimethylbenzene, tetramethylbenzene, methyl naphthalene, solvent naphtha, amides such as N-methyl-2-pyrrolidone, glycerides of fatty acids, and vegetable oils such as soybean oil and rapeseed oil can be listed.

[0055] Examples of the binder, thickener, and fixative include starch, dextrin, cellulose, methyl cellulose, ethyl cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxymethyl starch, provinol, pullulan, sodium alginate, ammonium alginate, propylene glycol alginate, guar gum, locust bean gum, gum arabic, xanthan gum, gelatin, casein, polyvinyl alcohol, polyethylene oxide, polyethylene glycol, ethylene-propylene block polymer, sodium polyacrylate, and polyvinyl pyrrolidone.

[0056] There is no particular limitation on the dosage form of the control agent, and it may be in the form of emulsions, suspensions, powders, granules, tablets, hydrates, aqueous solvents, liquids, aqueous suspensions, granular hydrates, aerosols, pastes, oils, emulsions, and the like.

[0057] Examples of methods for attaching the control agent to plants include a method of applying the control agent to the surface or inside of leaves, a method of attaching the control agent to the surface or inside of leaves using a predetermined carrier, a method of spreading or supplying the control agent to leaves, and the like.

[0058] The amount of the control agent to be applied or spread can be appropriately selected depending on various conditions such as the concentration of the active ingredient, the form of the preparation, the type of target disease and crop, the degree of damage caused by the disease, the application site, application method, application period, and the amount and type of mixed and combined drugs and fertilizers used.

[0059] Embodiment 1:

[0060] Isolation of attenuated strain YC-31

[0061] From the Camellia oleifera fruit in the field of Yongding District, Zhangjiajie City, Hunan Province, the conventional tissue separation method was used to separate the tissue at the junction of the diseased and healthy parts, disinfected with 70% alcohol for 1 minute, disinfected with mercuric chloride for 1 minute, rinsed with sterile water three times, and then patted dry with sterilized filter paper, transferred to a PDA plate with sterilized tweezers, and inverted at 28°C. The grown colonies were transferred to a new PDA medium, purified by single spore separation, and stored at 4°C on a PDA slant for later use.

[0062] Embodiment 2:

[0063] Extraction and purification of double-stranded RNA from attenuated strain YC-31

[0064] The attenuated strain YC-31 of the present invention is cultured in liquid for 1 week, and then the mycelia are collected by filtration; about 0.1g of mycelia is ground into powder in liquid nitrogen, transferred to a centrifuge tube, and 700μL of STE (1M Tris-HCl, 0.5M EDTA, 5M NaCl, 10% SDS) is added, and the mixture is shaken for 3 minutes using a vortex shaker to fully mix; 700μL of RNA extraction phenol is added, and the mixture is shaken for 3 minutes, and centrifuged at 12000rpm at 4°C for 3 minutes; about 650μL of supernatant is taken, and an equal volume of a mixture of RNA extraction phenol, chloroform and isoamyl alcohol with a volume ratio of 25:24:1 is added, and the mixture is shaken for 3 minutes, and centrifuged at 12000rpm at 4°C for 3 minutes; about 500μL of supernatant is taken, two tubes are combined into one tube, 0.1g of cellulose powder and 200μL of anhydrous ethanol are added, the mixture is shaken for 5 minutes, and the mixture is left standing on ice for 10 minutes. Continue to oscillate for 3 minutes, 4°C 12000rpm 3 minutes; discard the supernatant, add 1020μL TE buffer (1M Tris-HCl, 0.5M EDTA, 5M NaCl; PH7.0) and 180μL anhydrous ethanol, oscillate for 1 minute, and centrifuge at 4°C 12000rpm for 3 minutes; discard the supernatant, add 420μL TE, oscillate for 3 minutes, and centrifuge at 4°C 12000rpm for 3 minutes; take about 400μL of the supernatant in a 1.5mL new centrifuge tube, add an equal volume of isopropanol-20℃ precipitation for 2h, centrifuge at 4°C 12000rpm for 15min, and discard the supernatant; add 1mL 70% ethanol, centrifuge at 12000rpm for 10min, discard the supernatant, repeat the washing once, thoroughly remove the residual ethanol, and add 30μL dd H2O to dissolve the precipitate; add 1.5μL DNaseI (RNase-free), 1μL S1 Nuclease and 1 / 5 volume of DNA Buffer was added and reacted at 37°C for 40 minutes to obtain the target double-stranded RNA.

[0065] Embodiment 3:

[0066] Full genome sequencing of double-stranded RNA of attenuated strain YC-31

[0067] Add 5' phosphorylated and 3' amino adapter primer Primer A to the 3' end of the double-stranded RNA, and then purify and recover the double-stranded RNA after adding the adapter. Then use random primers and Primer B primer (reverse complementary primer of Primer A) to reverse transcribe and synthesize cDNA. Use it as a template to synthesize cDNA, and then clone and sequence the terminal sequence. Use the fragments obtained by high-throughput sequencing to design gene-specific primers and Primer B primers for PCR. After purifying and recovering the obtained bands, connect them to the T vector, and transform Escherichia coli to screen for positive clones. Then sequence each positive clone. The full-length sequence of the genomic information of the fungal virus CaPV1 is obtained. The fungal virus CaPV1 is composed of 2 double-stranded RNAs (see Figure 3 ), the nucleotide sequences of the double-stranded RNAs are shown in SEQ ID NOs: 1 to 2. It should be noted that in order to replace the double-stranded RNA with cDNA for sequencing, "uracil" was replaced with "thymine" in the sequence listing.

[0068] The phylogenetic tree constructed based on the RdRp sequence of the fungal virus CaPV1 is shown in Figure 4 .

[0069] Embodiment 4:

[0070] Analysis of biochemical characteristics of the virus particles of the fungal virus CaPV1

[0071] Take several bottles of attenuated strain YC-31 expanded in PDA, filter and dry with sterile filter paper, grind to powder in liquid nitrogen; add 0.1M phosphate buffer (pH7.0) to the mycelium at a ratio of 1g dry mycelium powder to 4mL phosphate buffer, shake for 5min, centrifuge at 4℃10000rpm for 15min; aspirate the supernatant, add 10% volume of n-butanol:chloroform (1:1), shake for 5min, centrifuge at 4℃10000rpm for 30min; aspirate the supernatant, add 50% PEG6000 and 5M NaCl to make the final concentrations of 6% and 0.1M respectively, and place at 4℃ for precipitation overnight. Centrifuge at 4℃12000rpm for 30min, discard the supernatant, suspend the precipitate in 0.01M phosphate buffer (about 30ml, so that the virus particles are fully dissolved in the phosphate buffer), centrifuge at 4℃12000rpm for 30min, and keep the supernatant (about 30ml). Then, add the above supernatant into an ultra-high speed centrifuge tube, add 20% sucrose to the bottom, centrifuge at 100000g for 4 hours, and dissolve the obtained precipitate in a small amount of 0.01M phosphate buffer (pH 7.0). This solution is the crude extract of virus particles.

[0072] A portion of the crude extract of the virus particles was subjected to SDS-PAGE (8% gel, Tris-glycine buffer (pH 8.8), 20 mA, 90 minutes) electrophoresis, stained with CBB (Coomassie Brilliant Blue), and the molecular weight of the main component of the virus protein (capsid protein) was analyzed. The protein electrophoresis results are shown in Figure 5 , a protein band of about 40 kDa from virus particles was detected. Nucleic acid was extracted from the component where the 40 kDa protein was detected by SDS-phenol method, and two double-stranded RNAs of 1.6 to 1.8 kbp were detected (see Figure 5 ). Therefore, the existence of the virus particles of the fungal virus of the present invention can be confirmed through this example.

[0073] Embodiment 5:

[0074] Identification of viral particles outside the bacteria by electron microscopy

[0075] The strain YC-31 was cultured in a PDA medium, and virus particles were separated from the culture supernatant. The culture supernatant was centrifuged (10,000 g, 5 min), and then ultracentrifuged (100,000 g, 30 min) to obtain a precipitate containing virus particles. The precipitate was dissolved in 0.05 M phosphate buffer (pH 7.0, negatively stained with phosphotungstic acid or uranyl acetate, and observed under an electron microscope (magnification: ×20,000 to 40,000). As a result, the virus particles of the fungal virus CaPV1 of the present invention were identified by electron microscopy. The virus particles are regular hexagonal in shape of about 30 to 40 nm, and are enclosed in an envelope-like structure (see Figure 5 B). Therefore, this example confirmed that the virus particles of the fungal virus of the present invention were present in the liquid culture medium containing the fungal virus CaPV1.

[0076] Embodiment 6:

[0077] The attenuated strain YC-31 was subjected to protoplast elimination to obtain the detoxified strains YC-31-P23 and YC-31-P29.

[0078] The attenuated strain YC-31 provided by the present invention is activated on a PDA plate, and when young mycelia grow, the agar block containing mycelia is picked and transferred to a PD medium, and cultured for 12 to 24 hours at 28°C and 180rpm; the mycelia is collected by filtering with gauze, and then rinsed with sterile deionized water for 2 to 3 times, and then rinsed with 0.7M NaCl for 2 to 3 times, and an appropriate amount of mycelia is picked to 5mL of protoplast preparation solution, and placed at 30°C and 80rpm for shaking culture for 1 to 3h, and microscopic examination is performed until a large number of protoplasts are released. The protoplasts are collected by filtering with three layers of lens paper, centrifuged at 4°C, 6000g for 8min, and the protoplasts are collected. An appropriate amount of STC solution is added to suspend the protoplasts, centrifuged at 4°C, 6000g for 8min, and a small amount of STC is added to resuspend the protoplasts, and the enrichment of the protoplasts is observed by microscopic examination. After the protoplast suspension is diluted with STC at different gradients, it is coated on a regeneration medium plate. After 1 to 2 days, fresh single colonies were picked and cultured on PDA plates and verified by dsRNA extraction and RT-PCR.

[0079] Embodiment 7:

[0080] The fungal virus CaPV1 was successfully transformed into protoplasts through PEG-mediated protoplast transformation, and introduced into the detoxified strain YC-31-P23 to obtain the detoxified and re-toxified strain YC-31-P23-T1.

[0081] After extracting the CaPV1 virus particles according to Example 4, the protoplasts of the virus-free strain YC-31-P23 were prepared according to Example 6. 10 μL of virus particle extract was added to 100 μL of protoplast suspension, incubated on ice for 30 minutes, 1 mL of PTC was added, and the mixture was allowed to stand at room temperature for 30 minutes. The mixture was dripped onto the regeneration medium. After the mycelium covered the plate, the mycelium blocks were taken and inoculated onto the PDA plate. After culturing for 2-3 days, dsRNA extraction and RT-PCR verification were performed. The corresponding colony pictures are shown in the figure below. Figure 6 shown.

[0082] Embodiment 8:

[0083] The needle inoculation method was used to study whether the fungal virus CaPV1 of the present invention is effective in preventing and controlling plant pathogenic fungi.

[0084] The pears, camellia leaves and apples were surface disinfected with 75% ethanol and air-dried; wounds were formed on the surfaces of the pears, camellia leaves and apples with a sterilized pin; a 5 mm bacterial cake was cut from the edge of a PDA plate of fresh attenuated strain YC-31, detoxified strains YC-31-P23 and YC-31-P29, and detoxified and re-toxinized strain YC-31-P23-T1 cultured for 5 days and inoculated on the pears, camellia leaves and apples; the inoculum was placed in a clean transparent polystyrene box, moistened with cotton moistened with sterile water, cultured at a constant temperature of 28°C, each treatment was repeated three times, and the incidence of the disease was counted 14 days after inoculation.

[0085] Results Figure 7 The results showed that the lesions formed by the strain YC-31 of the present invention and the detoxified and re-recovered strain YC-31-P23-T1 were smaller than those formed by the detoxified strains YC-31-P23 and YC-31-P29, indicating that the fungal virus CaPV1 of the present invention is effective in preventing and controlling plant pathogenic fungi.

[0086] Embodiment 9:

[0087] The mycelial tips and spore morphology of the attenuated strain YC-31 and the detoxified strain YC-31-P23 of the present invention were observed using an electron microscope.

[0088] Use a 5mm diameter puncher to punch fresh attenuated strain YC-31 and detoxified strain YC-31-P23 hyphae and inoculate them in the center of the PDA medium. Insert a sterile coverslip at a 45° angle about 3 cm away from the hyphae block and place it in a 28°C constant temperature incubator for culture. Repeat each treatment three times. When the hyphae grow onto the coverslip, pick up the coverslip and cover it on a slide. Use an optical microscope to observe the morphology of the hyphae tip and record it.

[0089] Fresh mycelium blocks of attenuated strain YC-31 and detoxified strain YC-31-P23 were selected and placed in 100 mL of PD medium. The culture was shaken at 28 °C and 180 rpm. The mycelium was removed by filtration. 10 μL of spore liquid was placed on a glass slide and the spore morphology was observed and recorded using an optical microscope.

[0090] It was found that the hyphae of the attenuated strain YC-31 were sparse and had few branches (see Figure 8 The first figure), while the mycelium of the virus-free strain YC-31-P23 was denser and more branched (see Figure 8 The second figure), therefore, it is speculated that the fungal virus CaPV1 affects the growth of host mycelium. The attenuated strain YC-31 has abnormally long linear conidia, which are cylindrical, elliptical or long linear, with blunt ends or one end slightly pointed (see Figure 8 The third picture), the size is 10.1-26.7×3.9-8.9μm (av=15.92 +0.65×5.81 + 0.15, n = 50), while the conidia of the virus-free strain YC-31-P23 were cylindrical or elliptical, with blunt ends or one end slightly pointed, and the spore size was 7.5-15.2 × 3.5-6.4 μm (av = 12.04 + 0.28×4.83 + 0.08, n = 50), so CaPV1 affects the host conidia morphology (see Figure 8 (fourth picture).

[0091] Embodiment 10:

[0092] The hyphae of the virulent strain YC-31 and the toxin-free strain YC-31-P23 were stained with FM4-64 dye, and the endocytosis of hyphae was observed using a fluorescence microscope.

[0093] The hyphae cultured in MM liquid medium for 48 hours were collected and placed on a glass slide, and the lipid-affinity FM4-64 dye was dropped on the hyphae for different lengths of staining. After the staining, the hyphae were immediately rinsed with water three times to wash off the excess dye, and the mycelium was placed under a fluorescence microscope to observe the absorption of the dye.

[0094] Results Fig. 9 The results showed that the dye was absorbed very quickly in the virus-free strain YC-31-P23, while in the attenuated strain YC-31 of the present invention, the dye was significantly blocked from entering the hyphae, and only a small amount of dye was absorbed by the hyphae at 30 minutes. Therefore, the fungal virus CaPV1 affects the endocytosis of the host.

[0095] Embodiment 11:

[0096] The sensitivity of the attenuated strain YC-31 and the detoxified strain YC-31-P23 of the present invention to carbendazim, prochloraz, and azoxystrobin was tested.

[0097] Using the hyphae growth rate method, 97.17% carbendazim was prepared into PDA medium plates with concentrations of 0.01, 0.02, 0.04, 0.08, and 0.16 mg / L, 97% prochloraz was prepared into PDA medium plates with concentrations of 0.0125, 0.025, 0.05, 0.1, and 0.2 mg / L, and 98% azoxystrobin was prepared into PDA medium plates with concentrations of 2, 4, 8, 16, and 32 mg / L. The blank control was inoculated with PDA medium without bactericide. Each concentration was repeated 3 times. When preparing the culture medium, different concentrations of bactericide were added to the PDA medium at about 50°C after melting to prepare different final concentrations of drug-containing culture medium and PDA plates. A 5mm diameter puncher was used to punch the bacterial cake from the edge of the newly cultured colony for 5 days and inoculated in the center of the drug-containing and control PDA plates with different agents and concentrations. After inoculation, the cells were placed in a 28°C constant temperature incubator for 5 days. The colony diameter of each treatment was measured by the cross method, and the mycelial growth inhibition rate was calculated. The data were recorded and analyzed using SPSS 20.0 software. The toxicity curve was made with the inhibition rate as the y-axis and the logarithm of the concentration as the x-axis. The toxicity regression equation, correlation coefficient (r) and lethal concentration (EC 50 ).

[0098] Results Fig.10 The attenuated strain YC-31 of the present invention is toxic to carbendazim EC 50 The detoxified strain YC-31-P23 had an EC 50 The attenuated strain YC-31 of the present invention has an EC 50 The detoxified strain YC-31-P23 had an EC 50 The attenuated strain YC-31 of the present invention has an EC 50 The detoxified strain YC-31-P23 had an EC 50 It is 16.929 mg / L. This shows that the attenuated strain YC-31 of the present invention is more sensitive to carbendazim and prochloraz than the detoxified strain YC-31-P23, but is less sensitive to azoxystrobin than the detoxified strain YC-31-P23. It is speculated that CaPV1 affects the sensitivity of the host to the agent, thereby enhancing the sensitivity to carbendazim and prochloraz, while reducing the sensitivity to azoxystrobin.

[0099] Embodiment 12:

[0100] Study on the control of plant pathogenic fungi by the virus CaPV1 of the present invention

[0101] After extracting the virus particles of the fungal virus CaPV1 through Example 4, they were introduced into other non-toxic wild-type anthracnose bacteria Cf10-6 and LY5-1 (C. fructicola), Cs4-1 (C. spaethianum) and Cg2-1 (C. gloeosporioides) through PEG-mediated protoplast transformation. Cf10-6-V, LY5-1-V, Cs4-1-V, and Cg2-1-V represent strains infected with the virus. Therefore, the fungal virus CaPV1 can infect the host bacteria through particle transfection, so that the host bacteria contain the fungal virus, thereby reducing the pathogenicity of plant pathogenic fungi and achieving the purpose of biological control of plant fungal diseases, such as Fig.11 shown.

[0102] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.

Claims

1. A fungal virus isolated from a strain with a preservation number of CCTCC NO: M20221146, which has the function of inhibiting plant disease fungi and has two double-stranded RNAs of 1.6 to 1.8 kb. The nucleotide sequences of the two double-stranded RNAs are shown in SEQ ID NOs: 1 and 2.

2. An attenuated strain containing the fungal virus according to claim 1, which is classified and named as Colletotrichum alienum YC-31 and has a deposit number of CCTCC NO: M20221146.

3. A plant disease control agent comprising the fungal virus according to claim 1 and / or the attenuated strain according to claim 2.

4. Use of the fungal virus according to claim 1 or the attenuated strain according to claim 2 in the preparation of a plant disease control agent caused by anthrax.

5. A method for attenuating plant pathogenic fungi, comprising using the fungal virus according to claim 1 to infect anthrax in vitro.

6. A method for controlling plant pathogenic fungi, comprising adding the plant disease control agent according to claim 3 to plants.